Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis

Cutaneous leishmaniasis (CL) is treated with painful intralesional injections of meglumine antimoniate (MA). With the aim of developing an alternative topical treatment for CL, a gel-based formulation with 30% MA was prepared and its physicochemical properties, stability and rheological behavior wer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceutics
Main Authors: Berenguer, Diana, Sosa, Lilian, Alcover, Magdalena, Sessa, Marcella, Halbaut, Lyda, Guillén, Carme, Fisa, Roser, Calpena-Campmany, Ana Cristina, Riera, Cristina
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6920791/
https://ncbi.nlm.nih.gov/pubmed/31731660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11110613
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados